Formulation and evaluation of fast dissolving films for delivery of triclosan to the oral cavity

AAPS PharmSciTech

Volumn 9, Issue 2, 2008, Pages 349-356

  Dinge, Aditya ^a   Nagarsenker, Mangal ^a  

^a BOMBAY COLLEGE OF PHARMACY   (India)

Author keywords

Fast dissolving films; Hydroxypropyl cyclodextrin; Poloxamer 407; Triclosan

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; EUGENOL; HYDROXYPROPYLMETHYLCELLULOSE; POLOXAMER; TRICLOSAN; XANTHAN; XYLITOL; 2-HYDROXYPROPYL-BETA-CYCLODEXTRIN; BACTERIAL POLYSACCHARIDE; BETA CYCLODEXTRIN DERIVATIVE; EXCIPIENT; FLAVORING AGENT; TOPICAL ANTIINFECTIVE AGENT;

ANTIMICROBIAL ACTIVITY; ARTICLE; DISSOLUTION; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM COMPARISON; DRUG FORMULATION; DRUG SOLUBILITY; DRUG STABILITY; FILM COATING; HUMAN; HUMAN EXPERIMENT; IN VITRO STUDY; IN VIVO STUDY; MOUTH CAVITY; NONHUMAN; TASTE; CHEMISTRY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DOSAGE FORM; DRUG EFFECT; FEMALE; GROWTH, DEVELOPMENT AND AGING; KINETICS; MALE; MOUTH; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SOLUBILITY; STREPTOCOCCUS MUTANS; TOPICAL DRUG ADMINISTRATION; X RAY DIFFRACTION;

ADMINISTRATION, ORAL; ADMINISTRATION, TOPICAL; ANTI-INFECTIVE AGENTS, LOCAL; BETA-CYCLODEXTRINS; CALORIMETRY, DIFFERENTIAL SCANNING; CHEMISTRY, PHARMACEUTICAL; DOSAGE FORMS; DRUG COMPOUNDING; DRUG STABILITY; EUGENOL; EXCIPIENTS; FEMALE; FLAVORING AGENTS; HUMANS; KINETICS; MALE; MOUTH; POLOXAMER; POLYSACCHARIDES, BACTERIAL; SINGLE-BLIND METHOD; SOLUBILITY; STREPTOCOCCUS MUTANS; TASTE; TRICLOSAN; X-RAY DIFFRACTION; XYLITOL;

EID: 51449107589     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-008-9047-7     Document Type: Article

References (20)

1. H. P. Nissen, and D. Ochs. Triclosan an antimicrobial active ingredient with anti-inflammatory activity. Cosm. Toilet. 113: 61-64 (1998).
2. N. Surolia, and A. Surolia. Triclosan offers protection against blood stages of Malaria by inhibiting enoyl ACP reductase of Plasmodium falciparum. Nat. Med. 7: 167-173 (2001).
3. J. Regos, and H. R. Hitz. Antimicrobial spectrum of triclosan: A broad spectrum antimicrobial agent. Zbl. Bakt. Hyg. A Orig. A. 226: 390-401 (1974).
4. R. J. Jackson. Metal salts, essential oils and phenols- old or new. Periodontol. 15: 63-73 (1997).
5. A. Scheie. Modes of action of currently known chemical anti plaque agents other than chlorhexidine. J. Dent. Res. 68: 1609-1616 (1989).
6. D. J. Bradshaw, P. D. Marsh, G. K. Watson, and D. Cummins. Effects of triclosan and zinc citrate, alone and in combination, on a community of oral bacteria grown in vitro. J. Dent. Res. 72: 25-30 (1993).
7. Y. J. Lin. Buccal absorption of triclosan following topical mouthrinse application. Am. J. Dent. 13: 215-217 (2000).
8. S. B. Borsadia, D. O'Halloran, and J. L. Osborne. Quick-dissolving films - a novel approach to drug delivery. Drug Delivery Technology. 2 (2) (2003). Available at http://www.drugdeliverytech.com/cgi-bin/ articles.cgi?idArticle. Accessed July 3, 2003.
9. A. C. Liang, and L. Chen. Fast dissolving intraoral drug delivery systems. Expert Opin. Ther. Pat. 11: 981-986 (2001).
10. T. Loftsson, N. Leeves, B. Bjonsdottir, L. Duffy, and M. Masson. Effect of cyclodextrins and polymers on triclosan availability and substantivity in toothpastes in vivo. J. Pharm. Sci. 88: 1254-1258 (1999).
11. M. S. Nagarsenker, and G. Ramprakash. Influence of preparation methodology on solid-state properties of an acidic drug-cyclodextrin system. J. Pharm. Pharmacol. 56: 725-733 (2004).
12. S. Hamada, and H. D. Slade. Immunology and Cariogenicity of Streptococcus mutans. Microbiol. Rev. 44: 331-384 (1980).
13. A. G. Jagtap, and S. G. Karkera. Extract of Juglandaceae regia inhibits growth, in-vitro adherence, acid production and aggregation of Streptococcus mutans. J. Pharm. Pharmacol. 52: 235-242 (2000).
14. J. E. Polli, G. S. Rekhi, L. L. Augsburger, and V. P. Shah. Methods to compare dissolution profiles and a rationale for wide dissolution specifications for metoprolol tartrate tablets. J. Pharm. Sci. 86: 690-700 (1997).
15. K. K. Peh, and C. F. Wong. Polymeric films as vehicle for buccal delivery: Swelling, mechanical, and bioadhesive properties. J. Pharm. Pharmcol. Sci. 2: 53-61 (1999).
16. D. M. Brahmankar, and S. B. Jaiswal. Biopharmaceutics and Pharmacokinetics: A Treatise. Vallabh Prakashan, New Delhi, India, 2003, pp. 178-203.
17. C. Grove, D. J. Liebenberg, W. Yang, and M. M. de Villiers. Improving the aqueous solubility of triclosan by solubilization, complex formation and in situ salt formation. J. Cosmet. Sci. 54: 537-550 (2003).
18. R. G. Strickley. Solubilizing excipients in oral and injectable formulations. Pharm. Res. 21: 201-229 (2004).
19. T. Coenye, K. Honraet, P. Rigole, P. M. Jimenez, and H. J. Nelis. In vitro inhibition of streptococcus mutans biofilm formation on hydroxyapatite by subinhibitory concentrations of anthraquinones. Antimicro. Agents Chemother. 51: 1541-1544 (2007).
20. J. M. Goodson. Pharmacokinetic principles controlling of oral therapy. J. Dent. Res. 68: 1625-1632 (1989).